Kerala Ayurveda Ltd vs Marksans Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 11, 2026

Key Highlights

The Latest Trading Price of Kerala Ayurveda Ltd is ₹ 236 as of 11 May 10:11 . The P/E Ratio of Kerala Ayurveda Ltd changed from 34.9 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Marksans Pharma Ltd changed from 8.7 on March 2021 to 26.5 on March 2025 . This represents a CAGR of 24.95% over 5 years The Market Cap of Kerala Ayurveda Ltd changed from ₹ 54.23 crore on March 2021 to ₹ 422.58 crore on March 2025 . This represents a CAGR of 50.78% over 5 yearsThe Market Cap of Marksans Pharma Ltd changed from ₹ 2044 crore on March 2021 to ₹ 10076 crore on March 2025 . This represents a CAGR of 37.58% over 5 years The revenue of Kerala Ayurveda Ltd for the Dec '25 is ₹ 34.09 crore as compare to the Sep '25 revenue of ₹ 36.54 crore. This represent the decline of -6.7% The revenue of Marksans Pharma Ltd for the Dec '25 is ₹ 774.57 crore as compare to the Sep '25 revenue of ₹ 741.98 crore. This represent the growth of 4.39% The ebitda of Kerala Ayurveda Ltd for the Dec '25 is ₹ -0.38 crore as compare to the Sep '25 ebitda of ₹ -3.25 crore. This represent the decline of -88.31% The ebitda of Marksans Pharma Ltd for the Dec '25 is ₹ 180.89 crore as compare to the Sep '25 ebitda of ₹ 166.07 crore. This represent the growth of 8.92% The net profit of Kerala Ayurveda Ltd changed from ₹ 0.46 crore to ₹ -4.6 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Marksans Pharma Ltd changed from ₹ 89.07 crore to ₹ 113.69 crore over 7 quarters. This represents a CAGR of 14.97% The Dividend Payout of Kerala Ayurveda Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Marksans Pharma Ltd changed from 10.4 % on March 2021 to 19.26 % on March 2025 . This represents a CAGR of 13.12% over 5 years .

About Kerala Ayurveda Ltd

Kerala Ayurveda Limited was established on 6th July 1992.
The Company is engaged in manufacture of Ayurveda products, Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services , cultivation of herbs and maintaining herbarium of medicinal plants.
The Company emerged as a frontline manufacturer of speciality patent ayurvedic medicines - tussnil, liposem and mathrukalpam. The company came out with a public issue in Feb.'95 to part-finance its 7-cr expansion-cum-diversification programme which involve, expansion of its existing facilities; to develop a fully integrated health care system, cultivate medicinal plants and market ayurvedic medicines.
It also envisions setting up a hospital. A modern facility to manufacture patent medicines, tablets, capsules and syrups, is to be set up at Athani, near Alwaye.

About Marksans Pharma Ltd

Marksans Pharma Limited was formerly incorporated as 'Tasc Pharmaceuticals Limited' in April, 1982.
Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited from 10th October, 2005.
The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation.
The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai. In 2004-05, the Company amalgamated with M/s.
Marksans Pharma Limited (formerly M/s.

FAQs for the comparison of Kerala Ayurveda Ltd and Marksans Pharma Ltd

Which company has a larger market capitalization, Kerala Ayurveda Ltd or Marksans Pharma Ltd?

Market cap of Kerala Ayurveda Ltd is 292 Cr while Market cap of Marksans Pharma Ltd is 8,968 Cr

What are the key factors driving the stock performance of Kerala Ayurveda Ltd and Marksans Pharma Ltd?

The stock performance of Kerala Ayurveda Ltd and Marksans Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kerala Ayurveda Ltd and Marksans Pharma Ltd?

As of May 11, 2026, the Kerala Ayurveda Ltd stock price is INR ₹225.35. On the other hand, Marksans Pharma Ltd stock price is INR ₹197.9.

How do dividend payouts of Kerala Ayurveda Ltd and Marksans Pharma Ltd compare?

To compare the dividend payouts of Kerala Ayurveda Ltd and Marksans Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.